Immediate Impact
1 by Nobel laureates 3 from Science/Nature 62 standout
Citing Papers
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
2024 Standout
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update
2022 Standout
Works of Mengdi Lu being referenced
Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Mengdi Lu | 248 | 16 | 36 | 266 | 70 | 15 | 458 | |
| Jonathan Frandsen | 117 | 13 | 41 | 54 | 62 | 23 | 424 | |
| Sujata Narayanan | 148 | 27 | 11 | 154 | 80 | 22 | 445 | |
| A. Curtis Hass | 96 | 21 | 88 | 86 | 136 | 19 | 571 | |
| J. A. Leeuw | 205 | 121 | 33 | 142 | 45 | 17 | 517 | |
| L. Scucchi | 177 | 5 | 32 | 59 | 23 | 22 | 467 | |
| Melissa K. James | 123 | 32 | 21 | 147 | 14 | 19 | 513 | |
| S.K. Landas | 140 | 3 | 39 | 83 | 19 | 22 | 487 | |
| J Cunningham | 112 | 23 | 108 | 89 | 138 | 14 | 480 | |
| Julio Sánchez de Cos | 292 | 4 | 9 | 150 | 66 | 14 | 479 | |
| Sandra M. J. Paulissen | 88 | 18 | 59 | 96 | 146 | 13 | 562 |
All Works
Login with ORCID to disown or claim papers
Loading papers...